Original InvestigationCost-Effectiveness of Revascularization Strategies: The ASCERT Study
Under an Elsevier user license
open archive
Key Words
coronary artery bypass graft
incremental cost-effectiveness ratio
percutaneous coronary intervention
stable ischemic heart disease
Abbreviations and Acronyms
ACCF
American College of Cardiology Foundation
CABG
coronary artery bypass graft
CAD
coronary artery disease
CI
confidence interval
DES
drug-eluting stent(s)
DRG
diagnosis-related group
ICER
incremental cost-effectiveness ratio
IPW
inverse probability-weighting
LYG
life-years gained
MI
myocardial infarction
PCI
percutaneous coronary intervention
PSBB
propensity score bin bootstrapping
QALY
quality-adjusted life-year
STS
Society of Thoracic Surgeons
Cited by (0)
This work is supported by a grant from the National Heart, Lung, and Blood Institute (#RC2HL101489) and by an Institutional Development Award from the National Institute of General Medical Sciences (#U54-GM104941) of the National Institutes of Health. Dr. Grover consults for, but does not receive fees from, Somalution. Dr. Garratt consults for The Medicines Company and Boston Scientific Corporation; and receives research support from Boston Scientific Corporation, DSI/Lily, CeloNova, and the Mayo Foundation. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Steven Nissen, MD, served as Guest Editor for this paper.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.